H.U. Group Holdings Inc
TSE:4544
Intrinsic Value
H.U.Group Holdings, Inc. provides the strategic planning, investor relations, public relations, and supervisory management of the entire group. [ Read More ]
The intrinsic value of one
H.U. Group Holdings Inc
stock under the Base Case scenario is
6 047.48
JPY.
Compared to the current market price of 2 406 JPY,
H.U. Group Holdings Inc
is
Undervalued by 60%.
H.U. Group Holdings Inc could be a value trap.A value trap occurs when a stock looks inexpensive based on fundamental analysis but fails to reach its intrinsic valuation over time, often due to underlying issues not reflected in quantitative data.
Scrutinize beyond numbers; assess long-term potential.
H.U. Group Holdings Inc's market capitalization is 136.7B JPY.
H.U. Group Holdings Inc stock price is 2 406 JPY.
H.U. Group Holdings Inc stock price (2406 JPY) is 60% less than its Intrinsic Value (6 047.48 JPY).
H.U. Group Holdings Inc stock price (2406 JPY) is 74% less than its DCF Value (9 114.4 JPY). Open DCF Valuation
H.U. Group Holdings Inc stock price (2406 JPY) is 19% less than its Relative Value (2 980.56 JPY). Open Relative Valuation
H.U. Group Holdings Inc has upside potential of 15% compared to the average analyst price target.
Open Wall St Estimates
H.U. Group Holdings Inc has positive three-year average ROIC (Return on Invested Capital): 10%. The company is efficient at using invested capital to generate operating income.
H.U. Group Holdings Inc's Revenue is forecast to grow at a rate of 0% per year over the next 3 years.
H.U. Group Holdings Inc has negative Operating Income for the last twelve months.
H.U. Group Holdings Inc has positive Net Debt. This means that the company has more debt (60B JPY) than cash and short-term investments (40B JPY).
H.U. Group Holdings Inc's Revenue has been growing by 5% per year for the last 3 years.
H.U. Group Holdings Inc has negative Net Income for the last twelve months.
H.U. Group Holdings Inc has positive three-year average ROE (Return on Equity): 15%. The company is efficient at transforming stockholders' equity into net income.
H.U. Group Holdings Inc's Revenue has dropped by 14% over the past 12 months.
H.U. Group Holdings Inc has positive Free Cash Flow for the last twelve months.
H.U. Group Holdings Inc's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -1%.
H.U. Group Holdings Inc's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from 12% to -1%.
H.U. Group Holdings Inc's ROE (Return on Equity) for the past 12 months is negative and is equal to -4%.
H.U. Group Holdings Inc's Altman Z-Score is equal to 2.06.
H.U. Group Holdings Inc's ROE (Return on Equity) has significantly decreased in the last 3 years from 16% to -4%.
H.U. Group Holdings Inc has positive Gross Profit for the last twelve months.
H.U. Group Holdings Inc's long-term assets (284B JPY) exceed its long-term liabilties (141B JPY).
H.U. Group Holdings Inc's short-term assets (120B JPY) exceed its short-term liabilties (58B JPY).
H.U. Group Holdings Inc's D/E (Debt to Equity) is very low and is equal to 0.42.
Valuation Backtest
H.U. Group Holdings Inc
Run backtest to discover the historical profit from buying and selling
H.U. Group Holdings Inc
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
H.U. Group Holdings Inc
Balance Sheet Decomposition
H.U. Group Holdings Inc
| Current Assets | 120.3B |
| Cash & Short-Term Investments | 40.4B |
| Receivables | 47.6B |
| Other Current Assets | 32.3B |
| Non-Current Assets | 163.8B |
| Long-Term Investments | 6.3B |
| PP&E | 78B |
| Intangibles | 43.4B |
| Other Non-Current Assets | 36.1B |
| Current Liabilities | 57.8B |
| Accounts Payable | 20.3B |
| Accrued Liabilities | 3.5B |
| Other Current Liabilities | 34B |
| Non-Current Liabilities | 83.1B |
| Long-Term Debt | 60.1B |
| Other Non-Current Liabilities | 23B |
Earnings Waterfall
H.U. Group Holdings Inc
|
Revenue
|
237.5B
JPY
|
|
Cost of Revenue
|
-171.8B
JPY
|
|
Gross Profit
|
65.6B
JPY
|
|
Operating Expenses
|
-67B
JPY
|
|
Operating Income
|
-1.4B
JPY
|
|
Other Expenses
|
-5B
JPY
|
|
Net Income
|
-6.5B
JPY
|
Free Cash Flow Analysis
H.U. Group Holdings Inc
Profitability Score
Profitability Due Diligence
H.U. Group Holdings Inc's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
Score
H.U. Group Holdings Inc's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
H.U. Group Holdings Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.
Score
H.U. Group Holdings Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
H.U. Group Holdings Inc
According to Wall Street analysts, the average 1-year price target for
H.U. Group Holdings Inc
is 2 756.55 JPY
with a low forecast of 2 232.1 JPY and a high forecast of 3 360 JPY.
Shareholder Return
Price
H.U. Group Holdings Inc
| Average Annual Return | 3.15% |
| Standard Deviation of Annual Returns | 7.19% |
| Max Drawdown | -32% |
| Market Capitalization | 136.7B JPY |
| Shares Outstanding | 56 819 124 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
H.U. Group Holdings Inc
Country
Industry
Market Cap
Dividend Yield
Description
H.U.Group Holdings, Inc. provides the strategic planning, investor relations, public relations, and supervisory management of the entire group. The company is headquartered in Shinjuku, Tokyo-To and currently employs 5,897 full-time employees. Group Holdings Inc, formerly Miraca Holdings Inc is a Japan-based holding company engaged in manufacture and sale of clinical test drugs, entrusted clinical examination and sterilization related business. The firm operates in four business segments. The Outsourced Clinical Testing segment accepts special tests from medical institutions. The Clinical Laboratory Medicine segment manufactures and sells clinical laboratory medicines and sells them to medical institutions and contract clinical laboratory companies. The Sterilization segment mainly entrusts the sterilization of medical equipment used for medical treatment in hospitals of large-scale hospitals and the related operations. The New Development & Others segment is involved in the homecare & welfare equipment business, self-medication & health insurance business, food & environment & cosmetics inspection business.
Contact
IPO
Employees
Officers
The intrinsic value of one
H.U. Group Holdings Inc
stock under the Base Case scenario is
6 047.48
JPY.
Compared to the current market price of 2 406 JPY,
H.U. Group Holdings Inc
is
Undervalued by 60%.
You don't have any saved screeners yet
